Robin Harper Cowie - 21 May 2024 Form 4 Insider Report for BIODESIX INC (BDSX)

Role
CFO, Sec'y & Treasurer
Signature
/s/ Robin Harper Cowie
Issuer symbol
BDSX
Transactions as of
21 May 2024
Net transactions value
+$1,768
Form type
4
Filing time
23 May 2024, 19:13:05 UTC
Previous filing
10 May 2024
Next filing
12 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDSX Common Stock Options Exercise $1,768 +4,209 +2.5% $0.4200 175,889 21 May 2024 Direct
transaction BDSX Common Stock Options Exercise +13,080 +7.4% 188,969 23 May 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSX Stock Options (Right to buy) Options Exercise $0 -4,209 -100% $0.000000* 0 21 May 2024 Common Stock 4,209 $0.4200 Direct F2
transaction BDSX Series A Non-Voting Convertible Preferred Stock Options Exercise $0 -327 -100% $0.000000* 0 23 May 2024 Common Stock 13,080 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024.
F2 This option vested in full on January 1, 2023.